Dr. Andrew Mahan started his career at Janssen in 1997 and is currently serving as the Associate Director and Mass Spec Group Leader within Cell Engineering and Analytical Sciences at Janssen Research. He and his team are focusing on providing innovative mass spec methods to develop high quality/high producing cell lines expressing biologics and deliver new molecule pipeline from Discovery to Development.